SOUN SoundHound AI | $1.95 +14.0% | 1/30/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $4.00 | Low | View details for LADENBURG THALM/SH SH rating of SoundHound AI (NASDAQ:SOUN) on 1/30/2024 |
OGE OGE Energy | $32.47 -0.6% | 1/16/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $36.00 -> $34.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 1/16/2024 |
SRE Sempra | $69.84 -0.3% | 1/3/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $81.50 | Low | View details for LADENBURG THALM/SH SH rating of Sempra (NYSE:SRE) on 1/3/2024 |
ED Consolidated Edison | $88.67 -0.9% | 1/3/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $92.50 | Low | View details for LADENBURG THALM/SH SH rating of Consolidated Edison (NYSE:ED) on 1/3/2024 |
PMVP PMV Pharmaceuticals | $1.69 -1.2% | 12/27/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | Low | View details for LADENBURG THALM/SH SH rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 12/27/2023 |
LQDA Liquidia | $14.68 +0.7% | 12/21/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $15.00 -> $30.00 | Low | View details for LADENBURG THALM/SH SH rating of Liquidia (NASDAQ:LQDA) on 12/21/2023 |
|
EVAX Evaxion Biotech A/S | $4.23 -1.2% | 12/21/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 12/21/2023 |
RPHM Reneo Pharmaceuticals | $1.65 +0.6% | 12/14/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/14/2023 |
ONDS Ondas | $1.31 +7.4% | 12/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.50 | Low | View details for LADENBURG THALM/SH SH rating of Ondas (NASDAQ:ONDS) on 12/11/2023 |
ALRN Aileron Therapeutics | $4.78 +7.2% | 12/1/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $9.00 | Low | View details for LADENBURG THALM/SH SH rating of Aileron Therapeutics (NASDAQ:ALRN) on 12/1/2023 |
OCCI OFS Credit | $6.97 -0.1% | 11/13/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of OFS Credit (NASDAQ:OCCI) on 11/13/2023 |
POR Portland General Electric | $39.59 -0.2% | 11/9/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $43.00 | Low | View details for LADENBURG THALM/SH SH rating of Portland General Electric (NYSE:POR) on 11/9/2023 |
NWE NorthWestern Energy Group | $47.08 +1.0% | 11/7/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $51.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 11/7/2023 |
CPK Chesapeake Utilities | $101.82 +1.9% | 10/12/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $100.00 | Low | View details for LADENBURG THALM/SH SH rating of Chesapeake Utilities (NYSE:CPK) on 10/12/2023 |
OGE OGE Energy | $32.47 -0.6% | 10/12/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $39.00 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 10/12/2023 |
ZURA Zura Bio | $3.92 -2.0% | 10/10/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Zura Bio (NASDAQ:ZURA) on 10/10/2023 |
NI NiSource | $25.06 -0.1% | 10/6/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $25.00 | Low | View details for LADENBURG THALM/SH SH rating of NiSource (NYSE:NI) on 10/6/2023 |
SABS SAB Biotherapeutics | $5.43 -2.0% | 10/5/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of SAB Biotherapeutics (NASDAQ:SABS) on 10/5/2023 |
COEP Coeptis Therapeutics | $0.48 -11.1% | 9/22/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.00 | Low | View details for LADENBURG THALM/SH SH rating of Coeptis Therapeutics (NASDAQ:COEP) on 9/22/2023 |
MRNS Marinus Pharmaceuticals | $9.99 +0.8% | 9/20/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $13.00 -> $15.50 | Low | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/20/2023 |
AEP American Electric Power | $75.94 -0.7% | 9/13/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 9/13/2023 |
WEC WEC Energy Group | $77.40 -1.0% | 9/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $85.00 | Low | View details for LADENBURG THALM/SH SH rating of WEC Energy Group (NYSE:WEC) on 9/11/2023 |
NWE NorthWestern Energy Group | $47.08 +1.0% | 8/17/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $59.00 -> $53.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 8/17/2023 |
CKPT Checkpoint Therapeutics | $1.99 +3.1% | 8/15/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $65.00 -> $47.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 8/15/2023 |
EIX Edison International | $64.73 -1.1% | 8/15/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 8/15/2023 |
CGTX Cognition Therapeutics | $2.25 -3.8% | 8/14/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $10.00 -> $6.00 | Low | View details for LADENBURG THALM/SH SH rating of Cognition Therapeutics (NASDAQ:CGTX) on 8/14/2023 |
PNNT PennantPark Investment | $6.76 -1.2% | 8/14/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $6.50 -> $7.00 | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Investment (NASDAQ:PNNT) on 8/14/2023 |
MRNS Marinus Pharmaceuticals | $9.99 +0.8% | 8/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $17.00 -> $13.00 | Low | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 8/11/2023 |
SLRC SLR Investment | $14.84 -0.6% | 8/11/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of SLR Investment (NASDAQ:SLRC) on 8/11/2023 |
HROW Harrow Health | $10.25 +3.9% | 8/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $33.70 -> $34.40 | Low | View details for LADENBURG THALM/SH SH rating of Harrow Health (NASDAQ:HROW) on 8/10/2023 |
SSKN STRATA Skin Sciences | $0.54
| 8/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $4.10 -> $3.80 | N/A | View details for LADENBURG THALM/SH SH rating of STRATA Skin Sciences (NASDAQ:SSKN) on 8/10/2023 |
SO Southern | $66.94 0.0% | 8/9/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $72.00 | Low | View details for LADENBURG THALM/SH SH rating of Southern (NYSE:SO) on 8/9/2023 |
WHF WhiteHorse Finance | $12.55 +0.2% | 8/9/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $13.00 | Low | View details for LADENBURG THALM/SH SH rating of WhiteHorse Finance (NASDAQ:WHF) on 8/9/2023 |
HTGC Hercules Capital | $17.18 +0.5% | 8/4/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $17.00 -> $18.50 | Low | View details for LADENBURG THALM/SH SH rating of Hercules Capital (NYSE:HTGC) on 8/4/2023 |
ARDX Ardelyx | $9.27 +3.3% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $7.50 -> $8.50 | Low | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 8/3/2023 |
CORT Corcept Therapeutics | $22.49 +1.0% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $44.00 -> $47.50 | Low | View details for LADENBURG THALM/SH SH rating of Corcept Therapeutics (NASDAQ:CORT) on 8/3/2023 |
UTHR United Therapeutics | $211.74 +0.5% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $256.00 -> $268.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 8/3/2023 |
URGN UroGen Pharma | $18.50 +15.5% | 7/31/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $47.00 -> $52.00 | Low | View details for LADENBURG THALM/SH SH rating of UroGen Pharma (NASDAQ:URGN) on 7/31/2023 |
NWE NorthWestern Energy Group | $47.08 +1.0% | 7/27/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $57.00 -> $59.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 7/27/2023 |
BLDE Blade Air Mobility | $3.03 +3.4% | 7/17/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $13.00 | Low | View details for LADENBURG THALM/SH SH rating of Blade Air Mobility (NASDAQ:BLDE) on 7/17/2023 |
|
CRVS Corvus Pharmaceuticals | $2.00 -3.4% | 7/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $10.00 -> $12.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 7/10/2023 |
LPTH LightPath Technologies | $1.55 -1.3% | 6/30/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of LightPath Technologies (NASDAQ:LPTH) on 6/30/2023 |
LNT Alliant Energy | $47.48 -0.6% | 6/16/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $52.50 | Low | View details for LADENBURG THALM/SH SH rating of Alliant Energy (NASDAQ:LNT) on 6/16/2023 |
OGE OGE Energy | $32.47 -0.6% | 6/15/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $37.00 -> $39.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 6/15/2023 |
NWE NorthWestern Energy Group | $47.08 +1.0% | 6/14/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $57.50 -> $57.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 6/14/2023 |
CRVS Corvus Pharmaceuticals | $2.00 -3.4% | 5/30/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $4.00 -> $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/30/2023 |
CKPT Checkpoint Therapeutics | $1.99 +3.1% | 5/17/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $69.00 -> $65.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 5/17/2023 |
EIX Edison International | $64.73 -1.1% | 5/17/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $66.00 -> $67.00 | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 5/17/2023 |
NWE NorthWestern Energy Group | $47.08 +1.0% | 5/17/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $57.50 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 5/17/2023 |
HROW Harrow Health | $10.25 +3.9% | 5/12/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $27.20 -> $32.40 | Low | View details for LADENBURG THALM/SH SH rating of Harrow Health (NASDAQ:HROW) on 5/12/2023 |
CDXC ChromaDex | $1.52 -1.3% | 5/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $7.50 -> $6.60 | Low | View details for LADENBURG THALM/SH SH rating of ChromaDex (NASDAQ:CDXC) on 5/11/2023 |
AADI Aadi Bioscience | $1.77 +1.1% | 5/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $47.00 -> $33.00 | Low | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 5/11/2023 |
BNGO Bionano Genomics | $1.18 +5.4% | 5/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $60.00 -> $48.00 | Low | View details for LADENBURG THALM/SH SH rating of Bionano Genomics (NASDAQ:BNGO) on 5/10/2023 |
CELH Celsius | $58.71 +1.6% | 5/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $36.67 -> $40.67 | Low | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 5/10/2023 |
SNCR Synchronoss Technologies | $6.07 -0.3% | 5/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $41.40 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 5/10/2023 |
SAR Saratoga Investment | $22.97 +0.7% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $28.00 -> $27.00 | Low | View details for LADENBURG THALM/SH SH rating of Saratoga Investment (NYSE:SAR) on 5/4/2023 |
OPK OPKO Health | $1.02 +2.0% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $5.75 -> $5.40 | Low | View details for LADENBURG THALM/SH SH rating of OPKO Health (NASDAQ:OPK) on 5/4/2023 |
TPVG TriplePoint Venture Growth BDC | $10.89 -0.5% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $14.50 -> $13.50 | Low | View details for LADENBURG THALM/SH SH rating of TriplePoint Venture Growth BDC (NYSE:TPVG) on 5/4/2023 |
UTHR United Therapeutics | $211.74 +0.5% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $285.00 -> $256.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 5/4/2023 |
AVDL Avadel Pharmaceuticals | $14.70 -0.1% | 5/2/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $14.50 -> $16.00 | Low | View details for LADENBURG THALM/SH SH rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 5/2/2023 |
VICI VICI Properties | $29.67 -0.1% | 5/1/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $34.50 -> $37.00 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 5/1/2023 |
TPST Tempest Therapeutics | $4.16 -1.0% | 4/28/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $8.00 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 4/28/2023 |
ACRV Acrivon Therapeutics | $3.54 -3.0% | 4/27/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $22.00 | Low | View details for LADENBURG THALM/SH SH rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/27/2023 |
OGE OGE Energy | $32.47 -0.6% | 4/20/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $37.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 4/20/2023 |
HRZN Horizon Technology Finance | $13.09
| 4/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.50 | Low | View details for LADENBURG THALM/SH SH rating of Horizon Technology Finance (NASDAQ:HRZN) on 4/11/2023 |
SCYX SCYNEXIS | $1.92 -4.0% | 4/3/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of SCYNEXIS (NASDAQ:SCYX) on 4/3/2023 |
MFIN Medallion Financial | $10.06 +2.3% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Medallion Financial (NASDAQ:MFIN) on 4/3/2023 |
EIX Edison International | $64.73 -1.1% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Sell | $66.00 | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 4/3/2023 |
ETR Entergy | $97.40 -0.2% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $116.00 | Low | View details for LADENBURG THALM/SH SH rating of Entergy (NYSE:ETR) on 4/3/2023 |
AEP American Electric Power | $75.94 -0.7% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Sell | $82.50 | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 4/3/2023 |
CKPT Checkpoint Therapeutics | $1.99 +3.1% | 4/3/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $96.00 -> $69.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 4/3/2023 |
PEG Public Service Enterprise Group | $58.21 -1.4% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $60.50 | Low | View details for LADENBURG THALM/SH SH rating of Public Service Enterprise Group (NYSE:PEG) on 4/3/2023 |
PCG PG&E | $16.24 -1.0% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $20.50 | Low | View details for LADENBURG THALM/SH SH rating of PG&E (NYSE:PCG) on 4/3/2023 |
ZYXI Zynex | $12.29 +0.7% | 3/28/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $27.00 -> $28.00 | Low | View details for LADENBURG THALM/SH SH rating of Zynex (NASDAQ:ZYXI) on 3/28/2023 |
EPRT Essential Properties Realty Trust | $24.62 +1.0% | 3/23/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $28.00 -> $27.00 | Low | View details for LADENBURG THALM/SH SH rating of Essential Properties Realty Trust (NYSE:EPRT) on 3/23/2023 |
EMAN eMagin | $2.07
| 3/16/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.00 | N/A | View details for LADENBURG THALM/SH SH rating of eMagin (NYSEAMERICAN:EMAN) on 3/16/2023 |
VRDN Viridian Therapeutics | $17.96 +1.2% | 3/9/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 3/9/2023 |
ADVM Adverum Biotechnologies | $1.97 -29.9% | 3/7/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $2.00 | Low | View details for LADENBURG THALM/SH SH rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/7/2023 |
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 3/2/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $35.00 | Low | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/2/2023 |
NYMT New York Mortgage Trust | $7.38 +0.4% | 2/24/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $12.00 | Low | View details for LADENBURG THALM/SH SH rating of New York Mortgage Trust (NASDAQ:NYMT) on 2/24/2023 |
UTHR United Therapeutics | $211.74 +0.5% | 2/23/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $295.00 -> $285.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 2/23/2023 |
NRBO NeuroBo Pharmaceuticals | $4.33 -6.3% | 12/7/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of NeuroBo Pharmaceuticals (NASDAQ:NRBO) on 12/7/2022 |
WHF WhiteHorse Finance | $12.55 +0.2% | 11/17/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $14.00 | Low | View details for LADENBURG THALM/SH SH rating of WhiteHorse Finance (NASDAQ:WHF) on 11/17/2022 |
CMPX Compass Therapeutics | $1.45 +8.2% | 11/16/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $9.00 | Low | View details for LADENBURG THALM/SH SH rating of Compass Therapeutics (NASDAQ:CMPX) on 11/16/2022 |
SNCR Synchronoss Technologies | $6.07 -0.3% | 11/15/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $41.40 | Low | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 11/15/2022 |
LPCN Lipocine | $4.01 +2.0% | 11/15/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $68.00 | Low | View details for LADENBURG THALM/SH SH rating of Lipocine (NASDAQ:LPCN) on 11/15/2022 |
AADI Aadi Bioscience | $1.77 +1.1% | 11/15/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $47.00 | N/A | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 11/15/2022 |
MDV Modiv Industrial | $14.85 +0.1% | 11/11/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $18.50 | Low | View details for LADENBURG THALM/SH SH rating of Modiv Industrial (NYSE:MDV) on 11/11/2022 |
NXTC NextCure | $1.30
| 11/4/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of NextCure (NASDAQ:NXTC) on 11/4/2022 |
GAIN Gladstone Investment | $13.62 +1.0% | 11/2/2022 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Gladstone Investment (NASDAQ:GAIN) on 11/2/2022 |
|
GTY Getty Realty | $27.25 +1.5% | 11/1/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $35.50 -> $34.00 | Low | View details for LADENBURG THALM/SH SH rating of Getty Realty (NYSE:GTY) on 11/1/2022 |
CAPR Capricor Therapeutics | $3.98 +1.8% | 10/26/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of Capricor Therapeutics (NASDAQ:CAPR) on 10/26/2022 |
VICI VICI Properties | $29.67 -0.1% | 10/12/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $36.00 -> $34.50 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 10/12/2022 |
CRVS Corvus Pharmaceuticals | $2.00 -3.4% | 10/7/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $2.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 10/7/2022 |
TPST Tempest Therapeutics | $4.16 -1.0% | 9/15/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $8.00 | Low | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 9/15/2022 |
PTN Palatin Technologies | $4.01 -2.0% | 9/9/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $50.00 | Low | View details for LADENBURG THALM/SH SH rating of Palatin Technologies (NYSEAMERICAN:PTN) on 9/9/2022 |
IMCR Immunocore | $74.93 -0.6% | 9/8/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $82.00 | Low | View details for LADENBURG THALM/SH SH rating of Immunocore (NASDAQ:IMCR) on 9/8/2022 |
VRDN Viridian Therapeutics | $17.96 +1.2% | 8/16/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $33.00 -> $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/16/2022 |
ORC Orchid Island Capital | $8.00 +0.1% | 8/15/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 8/15/2022 |
WRAP Wrap Technologies | $4.33 +9.3% | 8/12/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $4.25 -> $2.10 | Low | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 8/12/2022 |
ORC Orchid Island Capital | $8.00 +0.1% | 8/8/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 8/8/2022 |
FBIO Fortress Biotech | $1.80 +2.9% | 8/4/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $90.00 | Low | View details for LADENBURG THALM/SH SH rating of Fortress Biotech (NASDAQ:FBIO) on 8/4/2022 |
VICI VICI Properties | $29.67 -0.1% | 7/27/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $33.50 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 7/27/2022 |
ANEB Anebulo Pharmaceuticals | $2.47 -3.9% | 7/27/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | Low | View details for LADENBURG THALM/SH SH rating of Anebulo Pharmaceuticals (NASDAQ:ANEB) on 7/27/2022 |
LQDA Liquidia | $14.68 +0.7% | 7/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of Liquidia (NASDAQ:LQDA) on 7/22/2022 |
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 7/13/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $15.00 -> $23.00 | Low | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 7/13/2022 |
NVCT Nuvectis Pharma | $6.89 -1.0% | 7/13/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $21.00 | N/A | View details for LADENBURG THALM/SH SH rating of Nuvectis Pharma (NASDAQ:NVCT) on 7/13/2022 |
XAIR Beyond Air | $1.74 -3.3% | 6/29/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $17.00 -> $23.00 | Low | View details for LADENBURG THALM/SH SH rating of Beyond Air (NASDAQ:XAIR) on 6/29/2022 |
PAYS PaySign | $3.15 -2.5% | 5/17/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Neutral -> NA | $2.80 | Medium | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 5/17/2022 |
CELH Celsius | $58.71 +1.6% | 5/11/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $37.83 -> $40.00 | High | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 5/11/2022 |
ANVS Annovis Bio | $10.82 +9.2% | 5/2/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Annovis Bio (NYSE:ANVS) on 5/2/2022 |
RWAY Runway Growth Finance | $13.47 -0.1% | 4/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.50 | Low | View details for LADENBURG THALM/SH SH rating of Runway Growth Finance (NASDAQ:RWAY) on 4/22/2022 |
CGTX Cognition Therapeutics | $2.25 -3.8% | 4/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Cognition Therapeutics (NASDAQ:CGTX) on 4/22/2022 |
PAYS PaySign | $3.15 -2.5% | 3/24/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 3/24/2022 |
LFT Lument Finance Trust | $2.24 -0.4% | 3/17/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Lument Finance Trust (NYSE:LFT) on 3/17/2022 |
CMPX Compass Therapeutics | $1.45 +8.2% | 3/15/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | N/A | View details for LADENBURG THALM/SH SH rating of Compass Therapeutics (NASDAQ:CMPX) on 3/15/2022 |
WRAP Wrap Technologies | $4.33 +9.3% | 3/11/2022 | Target Lowered by | LADENBURG THALM/SH SH | Analyst Jon Hickman | Buy | $6.25 -> $5.25 | High | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 3/11/2022 |
SPRB Spruce Biosciences | $3.98 -2.7% | 3/8/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | High | View details for LADENBURG THALM/SH SH rating of Spruce Biosciences (NASDAQ:SPRB) on 3/8/2022 |
EPRT Essential Properties Realty Trust | $24.62 +1.0% | 3/1/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $27.00 -> $28.50 | Low | View details for LADENBURG THALM/SH SH rating of Essential Properties Realty Trust (NYSE:EPRT) on 3/1/2022 |
ONTX Onconova Therapeutics | $0.68
| 3/1/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | High | View details for LADENBURG THALM/SH SH rating of Onconova Therapeutics (NASDAQ:ONTX) on 3/1/2022 |
NXTC NextCure | $1.30
| 3/1/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $16.00 | Low | View details for LADENBURG THALM/SH SH rating of NextCure (NASDAQ:NXTC) on 3/1/2022 |
UTHR United Therapeutics | $211.74 +0.5% | 2/25/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $231.00 -> $203.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 2/25/2022 |
BYRN Byrna Technologies | $8.89 +8.2% | 2/22/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $26.50 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Byrna Technologies (NASDAQ:BYRN) on 2/22/2022 |
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 2/17/2022 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $15.00 | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 2/17/2022 |
CKPT Checkpoint Therapeutics | $1.99 +3.1% | 1/26/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $200.00 -> $260.00 | Medium | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/26/2022 |
VRDN Viridian Therapeutics | $17.96 +1.2% | 12/21/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $36.00 | High | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/21/2021 |
ARDX Ardelyx | $9.27 +3.3% | 12/1/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $6.00 | High | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 12/1/2021 |
RPHM Reneo Pharmaceuticals | $1.65 +0.6% | 11/22/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $45.00 | Medium | View details for LADENBURG THALM/SH SH rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 11/22/2021 |
BWAY BrainsWay | $6.10 +2.9% | 11/17/2021 | Target Raised by | LADENBURG THALM/SH SH | Analyst Jeffrey Cohen | Buy | $16.00 -> $17.00 | Low | View details for LADENBURG THALM/SH SH rating of BrainsWay (NASDAQ:BWAY) on 11/17/2021 |
WRAP Wrap Technologies | $4.33 +9.3% | 10/29/2021 | Target Lowered by | LADENBURG THALM/SH SH | Analyst Jon Hickman | Buy | $9.40 -> $6.75 | Medium | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 10/29/2021 |
ARDX Ardelyx | $9.27 +3.3% | 10/14/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 10/14/2021 |
BCYP Big Cypress Acquisition | $8.44 -19.2% | 10/1/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $16.50 | Low | View details for LADENBURG THALM/SH SH rating of Big Cypress Acquisition (OTCMKTS:BCYP) on 10/1/2021 |
PTN Palatin Technologies | $4.01 -2.0% | 9/30/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $50.00 | N/A | View details for LADENBURG THALM/SH SH rating of Palatin Technologies (NYSEAMERICAN:PTN) on 9/30/2021 |
AADI Aadi Bioscience | $1.77 +1.1% | 9/14/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $51.00 | Low | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 9/14/2021 |
FBRX Forte Biosciences | $0.63 +6.8% | 9/3/2021 | Downgraded by | LADENBURG THALM/SH SH | Analyst Michael Higgins | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Forte Biosciences (NASDAQ:FBRX) on 9/3/2021 |
LRFC Logan Ridge Finance | $22.38 -0.2% | 8/17/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $32.00 | High | View details for LADENBURG THALM/SH SH rating of Logan Ridge Finance (NASDAQ:LRFC) on 8/17/2021 |
PAYS PaySign | $3.15 -2.5% | 8/12/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $3.50 -> $3.75 | High | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 8/12/2021 |
LFT Lument Finance Trust | $2.24 -0.4% | 8/10/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $4.50 | High | View details for LADENBURG THALM/SH SH rating of Lument Finance Trust (NYSE:LFT) on 8/10/2021 |
PFLT PennantPark Floating Rate Capital | $11.30 +1.3% | 8/9/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $13.50 | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 8/9/2021 |
OFS OFS Capital | $11.49 -1.5% | 8/9/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $11.50 | Medium | View details for LADENBURG THALM/SH SH rating of OFS Capital (NASDAQ:OFS) on 8/9/2021 |
|
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 8/4/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 8/4/2021 |
IMMP Immutep | $2.35 -1.3% | 8/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $8.30 | Medium | View details for LADENBURG THALM/SH SH rating of Immutep (NASDAQ:IMMP) on 8/3/2021 |
ECOR electroCore | $7.14 -1.4% | 7/27/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $13.95 | Low | View details for LADENBURG THALM/SH SH rating of electroCore (NASDAQ:ECOR) on 7/27/2021 |
LAND Gladstone Land | $13.51 +0.7% | 7/21/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Gladstone Land (NASDAQ:LAND) on 7/21/2021 |
ARDX Ardelyx | $9.27 +3.3% | 7/20/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $6.50 -> $15.00 | N/A | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 7/20/2021 |
HROW Harrow Health | $10.25 +3.9% | 7/2/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $14.25 | Medium | View details for LADENBURG THALM/SH SH rating of Harrow Health (NASDAQ:HROW) on 7/2/2021 |
SNCR Synchronoss Technologies | $6.07 -0.3% | 6/23/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $66.60 | High | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 6/23/2021 |
EVAX Evaxion Biotech A/S | $4.23 -1.2% | 6/23/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $230.00 | High | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 6/23/2021 |
XAIR Beyond Air | $1.74 -3.3% | 6/22/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $17.00 | Low | View details for LADENBURG THALM/SH SH rating of Beyond Air (NASDAQ:XAIR) on 6/22/2021 |
OPK OPKO Health | $1.02 +2.0% | 6/21/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | Medium | View details for LADENBURG THALM/SH SH rating of OPKO Health (NASDAQ:OPK) on 6/21/2021 |
AYTU Aytu BioPharma | $2.65 +4.7% | 6/18/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $14.50 | High | View details for LADENBURG THALM/SH SH rating of Aytu BioPharma (NASDAQ:AYTU) on 6/18/2021 |
GRWG GrowGeneration | $2.30 +2.7% | 5/14/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $45.00 | High | View details for LADENBURG THALM/SH SH rating of GrowGeneration (NASDAQ:GRWG) on 5/14/2021 |
TSLX Sixth Street Specialty Lending | $21.31 -0.6% | 5/12/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Sixth Street Specialty Lending (NYSE:TSLX) on 5/12/2021 |
ATXS Astria Therapeutics | $15.26 +3.2% | 5/12/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $36.00 | High | View details for LADENBURG THALM/SH SH rating of Astria Therapeutics (NASDAQ:ATXS) on 5/12/2021 |
PAYS PaySign | $3.15 -2.5% | 5/12/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | $3.50 | High | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 5/12/2021 |
TRIN Trinity Capital | $13.97 +0.2% | 5/7/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $17.00 | Medium | View details for LADENBURG THALM/SH SH rating of Trinity Capital (NASDAQ:TRIN) on 5/7/2021 |
TSLX Sixth Street Specialty Lending | $21.31 -0.6% | 5/6/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Sixth Street Specialty Lending (NYSE:TSLX) on 5/6/2021 |
BYRN Byrna Technologies | $8.89 +8.2% | 5/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $26.50 | Low | View details for LADENBURG THALM/SH SH rating of Byrna Technologies (NASDAQ:BYRN) on 5/3/2021 |
OXSQ Oxford Square Capital | $3.03 -0.3% | 5/3/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Oxford Square Capital (NASDAQ:OXSQ) on 5/3/2021 |
WRAP Wrap Technologies | $4.33 +9.3% | 5/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $26.50 | Low | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 5/3/2021 |
RTX RTX | $91.04 -1.0% | 5/3/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $100.00 | Low | View details for LADENBURG THALM/SH SH rating of RTX (NYSE:RTX) on 5/3/2021 |
GLPI Gaming and Leisure Properties | $45.39 +0.2% | 4/26/2021 | Target Raised by | LADENBURG THALM/SH SH | - | | $47.50 -> $51.00 | Low | View details for LADENBURG THALM/SH SH rating of Gaming and Leisure Properties (NASDAQ:GLPI) on 4/26/2021 |
VICI VICI Properties | $29.67 -0.1% | 4/26/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $28.00 -> $33.50 | Medium | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 4/26/2021 |
NNOX Nano-X Imaging | $5.74 +1.6% | 4/26/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $52.00 | Low | View details for LADENBURG THALM/SH SH rating of Nano-X Imaging (NASDAQ:NNOX) on 4/26/2021 |
AFCG AFC Gamma | $11.33 +0.8% | 4/19/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of AFC Gamma (NASDAQ:AFCG) on 4/19/2021 |
NNOX Nano-X Imaging | $5.74 +1.6% | 4/19/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Nano-X Imaging (NASDAQ:NNOX) on 4/19/2021 |
AFCG AFC Gamma | $11.33 +0.8% | 4/12/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of AFC Gamma (NASDAQ:AFCG) on 4/12/2021 |
IZEA IZEA Worldwide | $1.94 -1.0% | 4/6/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | $18.00 | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 4/6/2021 |
OXSQ Oxford Square Capital | $3.03 -0.3% | 3/23/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Oxford Square Capital (NASDAQ:OXSQ) on 3/23/2021 |
CELH Celsius | $58.71 +1.6% | 3/11/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 3/11/2021 |
EVAX Evaxion Biotech A/S | $4.23 -1.2% | 3/2/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 3/2/2021 |
TRIN Trinity Capital | $13.97 +0.2% | 2/23/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Trinity Capital (NASDAQ:TRIN) on 2/23/2021 |
ARR ARMOUR Residential REIT | $18.56 +0.4% | 2/18/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of ARMOUR Residential REIT (NYSE:ARR) on 2/18/2021 |
OTLK Outlook Therapeutics | $0.45 +7.2% | 2/17/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | Low | View details for LADENBURG THALM/SH SH rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/17/2021 |
AVXL Anavex Life Sciences | $5.69 +1.8% | 2/17/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | Low | View details for LADENBURG THALM/SH SH rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/17/2021 |
APPS Digital Turbine | $3.81 -24.4% | 2/4/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 2/4/2021 |
JUSHF Jushi | $0.98
| 2/4/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Jushi (OTCMKTS:JUSHF) on 2/4/2021 |
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 1/27/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $43.00 -> $60.00 | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 1/27/2021 |
IZEA IZEA Worldwide | $1.94 -1.0% | 1/26/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 1/26/2021 |
VRDN Viridian Therapeutics | $17.96 +1.2% | 1/25/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 1/25/2021 |
UTHR United Therapeutics | $211.74 +0.5% | 1/20/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $151.00 -> $199.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 1/20/2021 |
VCEL Vericel | $45.85 +3.7% | 1/19/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $27.50 -> $44.00 | Low | View details for LADENBURG THALM/SH SH rating of Vericel (NASDAQ:VCEL) on 1/19/2021 |
GRWG GrowGeneration | $2.30 +2.7% | 1/12/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of GrowGeneration (NASDAQ:GRWG) on 1/12/2021 |
SAR Saratoga Investment | $22.97 +0.7% | 1/7/2021 | Target Raised by | LADENBURG THALM/SH SH | - | In-Line -> Buy | $21.00 -> $25.00 | Low | View details for LADENBURG THALM/SH SH rating of Saratoga Investment (NYSE:SAR) on 1/7/2021 |
TPST Tempest Therapeutics | $4.16 -1.0% | 1/6/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 1/6/2021 |
IIPR Innovative Industrial Properties | $91.32 +1.5% | 12/23/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2020 |
GLPI Gaming and Leisure Properties | $45.39 +0.2% | 12/11/2020 | Target Raised by | LADENBURG THALM/SH SH | - | | $31.50 -> $47.50 | Medium | View details for LADENBURG THALM/SH SH rating of Gaming and Leisure Properties (NASDAQ:GLPI) on 12/11/2020 |
LPCN Lipocine | $4.01 +2.0% | 12/10/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $51.00 | High | View details for LADENBURG THALM/SH SH rating of Lipocine (NASDAQ:LPCN) on 12/10/2020 |
BGNE BeiGene | $142.88 -3.3% | 12/8/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $278.00 | Low | View details for LADENBURG THALM/SH SH rating of BeiGene (NASDAQ:BGNE) on 12/8/2020 |
OVID Ovid Therapeutics | $3.75 +2.7% | 12/2/2020 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $21.00 -> $7.00 | High | View details for LADENBURG THALM/SH SH rating of Ovid Therapeutics (NASDAQ:OVID) on 12/2/2020 |
|
PNNT PennantPark Investment | $6.76 -1.2% | 11/20/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | Medium | View details for LADENBURG THALM/SH SH rating of PennantPark Investment (NASDAQ:PNNT) on 11/20/2020 |
PFLT PennantPark Floating Rate Capital | $11.30 +1.3% | 11/19/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 11/19/2020 |
ECC Eagle Point Credit | $9.96 +0.3% | 11/18/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $8.00 -> $10.00 | Medium | View details for LADENBURG THALM/SH SH rating of Eagle Point Credit (NYSE:ECC) on 11/18/2020 |
PAYS PaySign | $3.15 -2.5% | 11/18/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | $8.75 -> $3.30 | High | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 11/18/2020 |
IZEA IZEA Worldwide | $1.94 -1.0% | 11/13/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 11/13/2020 |
CELH Celsius | $58.71 +1.6% | 11/13/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $7.83 -> $9.67 | Medium | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 11/13/2020 |
TARS Tarsus Pharmaceuticals | $31.19 +4.9% | 11/10/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $42.00 | High | View details for LADENBURG THALM/SH SH rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/10/2020 |
BGNE BeiGene | $142.88 -3.3% | 11/9/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of BeiGene (NASDAQ:BGNE) on 11/9/2020 |
ORC Orchid Island Capital | $8.00 +0.1% | 10/30/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 10/30/2020 |
APPS Digital Turbine | $3.81 -24.4% | 10/30/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $21.00 -> $31.50 | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 10/30/2020 |
IMNM Immunome | $23.49 -5.7% | 10/26/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Immunome (NASDAQ:IMNM) on 10/26/2020 |
COGT Cogent Biosciences | $6.38 +7.2% | 10/14/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $4.00 | N/A | View details for LADENBURG THALM/SH SH rating of Cogent Biosciences (NASDAQ:COGT) on 10/14/2020 |
AVXL Anavex Life Sciences | $5.69 +1.8% | 9/28/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.00 | High | View details for LADENBURG THALM/SH SH rating of Anavex Life Sciences (NASDAQ:AVXL) on 9/28/2020 |
MRNS Marinus Pharmaceuticals | $9.99 +0.8% | 9/25/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | High | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/25/2020 |
BNGO Bionano Genomics | $1.18 +5.4% | 9/24/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.50 | Medium | View details for LADENBURG THALM/SH SH rating of Bionano Genomics (NASDAQ:BNGO) on 9/24/2020 |
LAND Gladstone Land | $13.51 +0.7% | 9/14/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $15.50 -> $16.50 | High | View details for LADENBURG THALM/SH SH rating of Gladstone Land (NASDAQ:LAND) on 9/14/2020 |
ACB Aurora Cannabis | $0.41 +2.5% | 9/8/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $9.00 | High | View details for LADENBURG THALM/SH SH rating of Aurora Cannabis (NASDAQ:ACB) on 9/8/2020 |
NVNO enVVeno Medical | $4.31 -2.0% | 9/3/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of enVVeno Medical (NASDAQ:NVNO) on 9/3/2020 |
SNCR Synchronoss Technologies | $6.07 -0.3% | 8/25/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $72.00 | Low | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 8/25/2020 |
PAYS PaySign | $3.15 -2.5% | 8/17/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $12.00 -> $8.75 | High | View details for LADENBURG THALM/SH SH rating of PaySign (NASDAQ:PAYS) on 8/17/2020 |
SSKN STRATA Skin Sciences | $0.54
| 8/12/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $3.75 | High | View details for LADENBURG THALM/SH SH rating of STRATA Skin Sciences (NASDAQ:SSKN) on 8/12/2020 |
SCYX SCYNEXIS | $1.92 -4.0% | 8/11/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $25.00 | High | View details for LADENBURG THALM/SH SH rating of SCYNEXIS (NASDAQ:SCYX) on 8/11/2020 |
NEWT NewtekOne | $11.18 +1.4% | 8/11/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of NewtekOne (NASDAQ:NEWT) on 8/11/2020 |
SACH Sachem Capital | $3.54 +2.9% | 8/10/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | N/A | View details for LADENBURG THALM/SH SH rating of Sachem Capital (NYSEAMERICAN:SACH) on 8/10/2020 |
FDUS Fidus Investment | $18.90 +0.6% | 8/10/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $11.50 | Medium | View details for LADENBURG THALM/SH SH rating of Fidus Investment (NASDAQ:FDUS) on 8/10/2020 |
RC Ready Capital | $8.88 +0.6% | 8/7/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Ready Capital (NYSE:RC) on 8/7/2020 |
ACHV Achieve Life Sciences | $4.37 -0.5% | 8/7/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $100.00 | Low | View details for LADENBURG THALM/SH SH rating of Achieve Life Sciences (NASDAQ:ACHV) on 8/7/2020 |
PWFL PowerFleet | $3.25 +0.6% | 8/7/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $6.00 -> $8.00 | Medium | View details for LADENBURG THALM/SH SH rating of PowerFleet (NASDAQ:PWFL) on 8/7/2020 |
CELH Celsius | $58.71 +1.6% | 8/7/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $3.92 -> $7.83 | High | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 8/7/2020 |
BGNE BeiGene | $142.88 -3.3% | 8/7/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $232.00 -> $268.00 | Medium | View details for LADENBURG THALM/SH SH rating of BeiGene (NASDAQ:BGNE) on 8/7/2020 |
SLRC SLR Investment | $14.84 -0.6% | 8/7/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $18.00 | Medium | View details for LADENBURG THALM/SH SH rating of SLR Investment (NASDAQ:SLRC) on 8/7/2020 |
MRNS Marinus Pharmaceuticals | $9.99 +0.8% | 8/6/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $18.00 | Medium | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 8/6/2020 |
TSLX Sixth Street Specialty Lending | $21.31 -0.6% | 8/6/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $19.00 | Medium | View details for LADENBURG THALM/SH SH rating of Sixth Street Specialty Lending (NYSE:TSLX) on 8/6/2020 |
TPVG TriplePoint Venture Growth BDC | $10.89 -0.5% | 8/6/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $9.00 -> $12.00 | Medium | View details for LADENBURG THALM/SH SH rating of TriplePoint Venture Growth BDC (NYSE:TPVG) on 8/6/2020 |
IMUX Immunic | $1.22 +0.8% | 8/6/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $50.00 -> $57.00 | Low | View details for LADENBURG THALM/SH SH rating of Immunic (NASDAQ:IMUX) on 8/6/2020 |
APPS Digital Turbine | $3.81 -24.4% | 8/6/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 8/6/2020 |
KOPN Kopin | $2.22 +11.0% | 8/5/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $1.50 -> $2.50 | High | View details for LADENBURG THALM/SH SH rating of Kopin (NASDAQ:KOPN) on 8/5/2020 |
NVAX Novavax | $3.79 +0.3% | 8/5/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | $105.00 | High | View details for LADENBURG THALM/SH SH rating of Novavax (NASDAQ:NVAX) on 8/5/2020 |
WRTC Wrap Technologies | $4.33 +9.3% | 7/31/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $9.75 -> $14.00 | High | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (OTCMKTS:WRTC) on 7/31/2020 |
DX Dynex Capital | $12.00 +1.3% | 7/29/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | Low | View details for LADENBURG THALM/SH SH rating of Dynex Capital (NYSE:DX) on 7/29/2020 |
LPTX Leap Therapeutics | $3.45 -1.7% | 7/19/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Market Perform -> Buy | $80.00 | High | View details for LADENBURG THALM/SH SH rating of Leap Therapeutics (NASDAQ:LPTX) on 7/19/2020 |
EYEN Eyenovia | $1.78 +0.6% | 7/19/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Buy | $19.00 | High | View details for LADENBURG THALM/SH SH rating of Eyenovia (NASDAQ:EYEN) on 7/19/2020 |
RYTM Rhythm Pharmaceuticals | $47.55 -0.5% | 7/16/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $43.00 | Low | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 7/16/2020 |
CKPT Checkpoint Therapeutics | $1.99 +3.1% | 7/15/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $200.00 | Medium | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 7/15/2020 |
OVID Ovid Therapeutics | $3.75 +2.7% | 7/13/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $21.00 | High | View details for LADENBURG THALM/SH SH rating of Ovid Therapeutics (NASDAQ:OVID) on 7/13/2020 |
NVAX Novavax | $3.79 +0.3% | 7/8/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $50.00 -> $105.00 | High | View details for LADENBURG THALM/SH SH rating of Novavax (NASDAQ:NVAX) on 7/8/2020 |
APPS Digital Turbine | $3.81 -24.4% | 7/7/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $12.25 | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 7/7/2020 |
IZEA IZEA Worldwide | $1.94 -1.0% | 6/26/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 6/26/2020 |
IIPR Innovative Industrial Properties | $91.32 +1.5% | 6/23/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $83.50 -> $104.00 | Low | View details for LADENBURG THALM/SH SH rating of Innovative Industrial Properties (NYSE:IIPR) on 6/23/2020 |
FBRX Forte Biosciences | $0.63 +6.8% | 6/22/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Forte Biosciences (NASDAQ:FBRX) on 6/22/2020 |
ARMP Armata Pharmaceuticals | $3.96 +4.8% | 6/22/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $9.00 | N/A | View details for LADENBURG THALM/SH SH rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 6/22/2020 |
LVO LiveOne | $1.49 +1.4% | 6/19/2020 | Target Raised by | LADENBURG THALM/SH SH | - | | $4.50 -> $5.75 | High | View details for LADENBURG THALM/SH SH rating of LiveOne (NASDAQ:LVO) on 6/19/2020 |
OVID Ovid Therapeutics | $3.75 +2.7% | 6/18/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | High | View details for LADENBURG THALM/SH SH rating of Ovid Therapeutics (NASDAQ:OVID) on 6/18/2020 |
IZEA IZEA Worldwide | $1.94 -1.0% | 6/16/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 6/16/2020 |
TRSSF TerrAscend | $2.18 -3.1% | 6/15/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of TerrAscend (OTCMKTS:TRSSF) on 6/15/2020 |
OTLK Outlook Therapeutics | $0.45 +7.2% | 6/4/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | Medium | View details for LADENBURG THALM/SH SH rating of Outlook Therapeutics (NASDAQ:OTLK) on 6/4/2020 |
CGC Canopy Growth | $4.11 -4.9% | 6/1/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020 |
MESO Mesoblast | $1.82 +1.7% | 5/28/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $26.00 -> $30.50 | Low | View details for LADENBURG THALM/SH SH rating of Mesoblast (NASDAQ:MESO) on 5/28/2020 |
ALPN Alpine Immune Sciences | $28.41 +4.8% | 5/26/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $17.00 | Medium | View details for LADENBURG THALM/SH SH rating of Alpine Immune Sciences (NASDAQ:ALPN) on 5/26/2020 |
USIO Usio | $1.67
| 5/22/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $4.50 | N/A | View details for LADENBURG THALM/SH SH rating of Usio (NASDAQ:USIO) on 5/22/2020 |